Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 2,400 shares, a drop of 98.4% from the November 30th total of 149,000 shares. Based on an average daily trading volume, of 2,072,800 shares, the short-interest ratio is presently 0.0 days.

Psykey Trading Down 4.5 %

Psykey stock traded down $0.00 during midday trading on Friday, reaching $0.03. 939,738 shares of the company were exchanged, compared to its average volume of 611,033. The firm’s 50-day simple moving average is $0.02 and its 200-day simple moving average is $0.02. Psykey has a 1 year low of $0.01 and a 1 year high of $0.05.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.